Imaging Atherosclerosis

Circulation Research

Volumn 118, Issue 4, 2016, Pages 750-769

  Tarkin, Jason M ^a   Dweck, Marc R ^b,d   Evans, Nicholas R ^a   Takx, Richard A P ^c   Brown, Adam J ^a   Tawakol, Ahmed ^c   Fayad, Zahi A ^d   Rudd, James H F ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; coronary artery disease; molecular imaging; multimodal imaging; risk factors

Indexed keywords

BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18; NANOPARTICLE;

ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DISEASE SEVERITY; ECHOGRAPHY; EXPERIMENTAL ATHEROSCLEROSIS; FUNCTIONAL IMAGING; HEART MUSCLE ISCHEMIA; HUMAN; HYPOXIA; IMAGING; INFLAMMATION; INTRAVASCULAR CORONARY IMAGING; INTRAVENOUS UROGRAPHY; MAGNETIC RESONANCE ANGIOGRAPHY; MOLECULAR IMAGING; MULTIMODAL IMAGING; NEOANGIOGENESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RADIATION EXPOSURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STENOSIS; ATHEROSCLEROTIC PLAQUE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; INTERVENTIONAL ULTRASONOGRAPHY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; X-RAY COMPUTED TOMOGRAPHY;

CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIMODAL IMAGING; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, OPTICAL COHERENCE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84959056312     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.115.306247     Document Type: Article

References (208)

1. Libby P., Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012 32 2045 2051. doi: 10.1161/ATVBAHA.108.179705.
2. Bentzon JF, Otsuka F, Virmani R, Falk E., Mechanisms of plaque formation and rupture. Circ Res 2014 114 1852 1866. doi: 10.1161/CIRCRESAHA.114.302721.
3. Go AS, Mozaffarian D, Roger VL, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014 129 e28 e292. doi: 10.1161/01.cir.0000441139.02102.80.
4. Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, Naghavi M., Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation 2014 129 1483 1492. doi: 10.1161/CIRCULATIONAHA.113.004042.
5. Joshi NV, Vesey AT, Williams MC, 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet 2014 383 705 713. doi: 10.1016/S0140-6736(13)61754-7.
6. Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, Brindis RG, Douglas PS., Low diagnostic yield of elective coronary angiography. N Engl J Med 2010 362 886 895. doi: 10.1056/NEJMoa0907272.
7. Marwick TH, Cho I, Ó Hartaigh B, Min JK., Finding the gatekeeper to the cardiac catheterization laboratory: coronary CT angiography or stress testing? J Am Coll Cardiol 2015 65 2747 2756. doi: 10.1016/j.jacc.2015.04.060.
8. Shaw LJ, Hausleiter J, Achenbach S, CONFIRM Registry Investigators Coronary computed tomographic angiography as a gatekeeper to invasive diagnostic and surgical procedures: results from the multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: an International Multicenter) registry. J Am Coll Cardiol 2012 60 2103 2114. doi: 10.1016/j.jacc.2012.05.062.
9. Miller JM, Rochitte CE, Dewey M, Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med 2008 359 2324 2336. doi: 10.1056/NEJMoa0806576.
10. Meijboom WB, Meijs MF, Schuijf JD, Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study. J Am Coll Cardiol 2008 52 2135 2144. doi: 10.1016/j.jacc.2008.08.058.
11. Hecht HS., Coronary artery calcium scanning: past, present, and future. JACC Cardiovasc Imaging 2015 8 579 596. doi: 10.1016/j.jcmg.2015.02.006.
12. Cho I, Chang HJ, Sung JM, CONFIRM Investigators Coronary computed tomographic angiography and risk of all-cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the CONFIRM Registry (coronary CT angiography evaluation for clinical outcomes: an international multicenter registry). Circulation 2012 126 304 313. doi: 10.1161/CIRCULATIONAHA.111.081380.
13. SCOT-HEART Investigators CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet 2015 385 2383 2391
14. Neglia D, Rovai D, Caselli C, EVINCI Study Investigators Detection of significant coronary artery disease by noninvasive anatomical and functional imaging. Circ Cardiovasc Imaging 2015 8 e002179 e002179. doi: 10.1161/CIRCIMAGING.114.002179.
15. Arbab-Zadeh A, Di Carli MF, Cerci R, Accuracy of computed tomographic angiography and single-photon emission computed tomography-acquired myocardial perfusion imaging for the diagnosis of coronary artery disease. Circ Cardiovasc Imaging 2015 8 e003533. doi: 10.1161/CIRCIMAGING.115.003533.
16. Hoffmann U, Truong QA, Schoenfeld DA, ROMICAT-II Investigators Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med 2012 367 299 308. doi: 10.1056/NEJMoa1201161.
17. Opolski MP, Achenbach S., CT angiography for revascularization of CTO: crossing the borders of diagnosis and treatment. JACC Cardiovasc Imaging 2015 8 846 858. doi: 10.1016/j.jcmg.2015.05.001.
18. Schulman-Marcus J, Danad I, Truong QA., State-of-the-art updates on cardiac computed tomographic angiography for assessing coronary artery disease. Curr Treat Options Cardiovasc Med 2015 17 398. doi: 10.1007/s11936-015-0398-6.
19. Yoshioka K, Tanaka R, Muranaka K, Sasaki T, Ueda T, Chiba T, Takeda K, Sugawara T., Subtraction coronary CT angiography using second-generation 320-detector row CT. Int J Cardiovasc Imaging 2015 31 Suppl 1 51 58. doi: 10.1007/s10554-015-0630-1.
20. Ishida M, Sakuma H., Coronary MR angiography revealed: how to optimize image quality. Magn Reson Imaging Clin N Am 2015 23 117 125. doi: 10.1016/j.mric.2014.09.008.
21. Makowski MR, Henningsson M, Spuentrup E, Kim WY, Maintz D, Manning WJ, Botnar RM., Characterization of coronary atherosclerosis by magnetic resonance imaging. Circulation 2013 128 1244 1255. doi: 10.1161/CIRCULATIONAHA.113.002681.
22. Sakuma H, Ichikawa Y, Chino S, Hirano T, Makino K, Takeda K., Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol 2006 48 1946 1950. doi: 10.1016/j.jacc.2006.07.055.
23. Kato S, Kitagawa K, Ishida N, Ishida M, Nagata M, Ichikawa Y, Katahira K, Matsumoto Y, Seo K, Ochiai R, Kobayashi Y, Sakuma H., Assessment of coronary artery disease using magnetic resonance coronary angiography: a national multicenter trial. J Am Coll Cardiol 2010 56 983 991. doi: 10.1016/j.jacc.2010.01.071.
24. Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E, Langerak SE, Weber OM, Pedersen EM, Schmidt M, Botnar RM, Manning WJ., Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001 345 1863 1869. doi: 10.1056/NEJMoa010866.
25. Yang Q, Li K, Liu X, Du X, Bi X, Huang F, Jerecic R, Liu Z, An J, Xu D, Zheng H, Fan Z, Li D., 3.0T whole-heart coronary magnetic resonance angiography performed with 32-channel cardiac coils: a single-center experience. Circ Cardiovasc Imaging 2012 5 573 579. doi: 10.1161/CIRCIMAGING.112.974972.
26. Yoon YE, Kitagawa K, Kato S, Ishida M, Nakajima H, Kurita T, Ito M, Sakuma H., Prognostic value of coronary magnetic resonance angiography for prediction of cardiac events in patients with suspected coronary artery disease. J Am Coll Cardiol 2012 60 2316 2322. doi: 10.1016/j.jacc.2012.07.060.
27. van Nunen LX, Zimmermann FM, Tonino PAL, FAME Study Investigators Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet 2015. [Epub ahead of print]. doi: 10.1016/S0140-6736(15)00057-4.
28. Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, Dorbala S, Blankstein R, Di Carli MF., Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 2015 131 19 27. doi: 10.1161/CIRCULATIONAHA.114.011939.
29. Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF., Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA 2008 300 1765 1773. doi: 10.1001/jama.300.15.1765.
30. Juneau D, Erthal F, Ohira H, Mc Ardle B, Hessian R, deKemp RA, Beanlands RS., Clinical PET myocardial perfusion imaging and flow quantification. Cardiol Clin 2016 34 69 85. doi: 10.1016/j.ccl.2015.07.013.
31. van de Hoef TP, Echavarria-Pinto M, van Lavieren MA, Meuwissen M, Serruys PWJC, Tijssen JGP, Pocock SJ, Escaned J, Piek JJ., Diagnostic and prognostic implications of coronary flow capacity: a comprehensive cross-modality physiological concept in ischemic heart disease. JACC Cardiovasc Interv 2015 8 1670 1680. doi: 10.1016/j.jcin.2015.05.032.
32. Rochitte CE, George RT, Chen MY, Computed tomography angiography and perfusion to assess coronary artery stenosis causing perfusion defects by single photon emission computed tomography: the CORE320 study. Eur Heart J 2014 35 1120 1130. doi: 10.1093/eurheartj/eht488.
33. Wong DT, Ko BS, Cameron JD, Leong DP, Leung MC, Malaiapan Y, Nerlekar N, Crossett M, Troupis J, Meredith IT, Seneviratne SK., Comparison of diagnostic accuracy of combined assessment using adenosine stress computed tomography perfusion + computed tomography angiography with transluminal attenuation gradient + computed tomography angiography against invasive fractional flow reserve. J Am Coll Cardiol 2014 63 1904 1912. doi: 10.1016/j.jacc.2014.02.557.
34. Bettencourt N, Chiribiri A, Schuster A, Direct comparison of cardiac magnetic resonance and multidetector computed tomography stress-rest perfusion imaging for detection of coronary artery disease. J Am Coll Cardiol 2013 61 1099 1107. doi: 10.1016/j.jacc.2012.12.020.
35. Lau AZ, Miller JJ, Robson MD, Tyler DJ., Cardiac perfusion imaging using hyperpolarized (13) c urea using flow sensitizing gradients. Magn Reson Med 2015. [Epub ahead of print]. doi: 10.1002/mrm.25713.
36. Virmani R, Burke AP, Farb A, Kolodgie FD., Pathology of the vulnerable plaque. J Am Coll Cardiol 2006 47 C13 C18. doi: 10.1016/j.jacc.2005.10.065.
37. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J., Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005 25 2054 2061. doi: 10.1161/01.ATV.0000178991.71605.18.
38. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R., Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010 30 1282 1292. doi: 10.1161/ATVBAHA.108.179739.
39. Narula J, Nakano M, Virmani R, Kolodgie FD, Petersen R, Newcomb R, Malik S, Fuster V, Finn AV., Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol 2013 61 1041 1051. doi: 10.1016/j.jacc.2012.10.054.
40. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM., Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 2006 113 2320 2328. doi: 10.1161/CIRCULATIONAHA.105.589044.
41. Howard DP, van Lammeren GW, Rothwell PM, Redgrave JN, Moll FL, de Vries JP, de Kleijn DP, den Ruijter HM, de Borst GJ, Pasterkamp G., Symptomatic carotid atherosclerotic disease: correlations between plaque composition and ipsilateral stroke risk. Stroke 2015 46 182 189. doi: 10.1161/STROKEAHA.114.007221.
42. Cheruvu PK, Finn AV, Gardner C, Caplan J, Goldstein J, Stone GW, Virmani R, Muller JE., Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll Cardiol 2007 50 940 949. doi: 10.1016/j.jacc.2007.04.086.
43. Nair A, Margolis MP, Kuban BD, Vince DG., Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. EuroIntervention 2007 3 113 120
44. Garcia-Garcia HM, Jang IK, Serruys PW, Kovacic JC, Narula J, Fayad ZA., Imaging plaques to predict and better manage patients with acute coronary events. Circ Res 2014 114 1904 1917. doi: 10.1161/CIRCRESAHA.114.302745.
45. Kume T, Akasaka T, Kawamoto T, Okura H, Watanabe N, Toyota E, Neishi Y, Sukmawan R, Sadahira Y, Yoshida K., Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J 2006 152 755.e1 755.e4. doi: 10.1016/j.ahj.2006.06.030.
46. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Kang DH, Halpern EF, Tearney GJ., Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002 106 1640 1645
47. Lindsay AC, Choudhury RP., Form to function: current and future roles for atherosclerosis imaging in drug development. Nat Rev Drug Discov 2008 7 517 529. doi: 10.1038/nrd2588.
48. Tearney GJ, Yabushita H, Houser SL, Aretz HT, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Halpern EF, Bouma BE., Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003 107 113 119
49. Phipps JE, Vela D, Hoyt T, Halaney DL, Mancuso JJ, Buja LM, Asmis R, Milner TE, Feldman MD., Macrophages and intravascular OCT bright spots: a quantitative study. JACC Cardiovasc Imaging 2015 8 63 72. doi: 10.1016/j.jcmg.2014.07.027.
50. Liu L, Gardecki JA, Nadkarni SK, Toussaint JD, Yagi Y, Bouma BE, Tearney GJ., Imaging the subcellular structure of human coronary atherosclerosis using micro-optical coherence tomography. Nat Med 2011 17 1010 1014. doi: 10.1038/nm.2409.
51. Brown AJ, Obaid DR, Costopoulos C, Parker RA, Calvert PA, Teng Z, Hoole SP, West NE, Goddard M, Bennett MR., direct comparison of virtual-histology intravascular ultrasound and optical coherence tomography imaging for identification of thin-cap fibroatheroma. Circ Cardiovasc Imaging 2015 8 e003487. doi: 10.1161/CIRCIMAGING.115.003487.
52. Caplan JD, Waxman S, Nesto RW, Muller JE., Near-infrared spectroscopy for the detection of vulnerable coronary artery plaques. J Am Coll Cardiol 2006 47 C92 C96. doi: 10.1016/j.jacc.2005.12.045.
53. Gardner CM, Tan H, Hull EL, Lisauskas JB, Sum ST, Meese TM, Jiang C, Madden SP, Caplan JD, Burke AP, Virmani R, Goldstein J, Muller JE., Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. JACC Cardiovasc Imaging 2008 1 638 648. doi: 10.1016/j.jcmg.2008.06.001.
54. Waxman S, Dixon SR, L'Allier P, Moses JW, Petersen JL, Cutlip D, Tardif JC, Nesto RW, Muller JE, Hendricks MJ, Sum ST, Gardner CM, Goldstein JA, Stone GW, Krucoff MW., In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. JACC Cardiovasc Imaging 2009 2 858 868. doi: 10.1016/j.jcmg.2009.05.001.
55. Roleder T, Kovacic JC, Ali Z, Sharma R, Cristea E, Moreno P, Sharma SK, Narula J, Kini AS., Combined NIRS and IVUS imaging detects vulnerable plaque using a single catheter system: a head-to-head comparison with OCT. EuroIntervention 2014 10 303 311. doi: 10.4244/EIJV10I3A53.
56. Maurovich-Horvat P, Ferencik M, Voros S, Merkely B, Hoffmann U., Comprehensive plaque assessment by coronary CT angiography. Nat Rev Cardiol 2014 11 390 402. doi: 10.1038/nrcardio.2014.60.
57. Otsuka M, Bruining N, Van Pelt NC, Quantification of coronary plaque by 64-slice computed tomography: a comparison with quantitative intracoronary ultrasound. Invest Radiol 2008 43 314 321. doi: 10.1097/RLI.0b013e31816a88a9.
58. van der Giessen AG, Toepker MH, Donelly PM, Bamberg F, Schlett CL, Raffle C, Irlbeck T, Lee H, van Walsum T, Maurovich-Horvat P, Gijsen FJ, Wentzel JJ, Hoffmann U., Reproducibility, accuracy, and predictors of accuracy for the detection of coronary atherosclerotic plaque composition by computed tomography: an ex vivo comparison to intravascular ultrasound. Invest Radiol 2010 45 693 701. doi: 10.1097/RLI.0b013e3181e0a541.
59. Voros S, Rinehart S, Qian Z, Vazquez G, Anderson H, Murrieta L, Wilmer C, Carlson H, Taylor K, Ballard W, Karmpaliotis D, Kalynych A, Brown C III., Prospective validation of standardized, 3-dimensional, quantitative coronary computed tomographic plaque measurements using radiofrequency backscatter intravascular ultrasound as reference standard in intermediate coronary arterial lesions: results from the ATLANTA (assessment of tissue characteristics, lesion morphology, and hemodynamics by angiography with fractional flow reserve, intravascular ultrasound and virtual histology, and noninvasive computed tomography in atherosclerotic plaques) I study. JACC Cardiovasc Interv 2011 4 198 208. doi: 10.1016/j.jcin.2010.10.008.
60. Ito T, Terashima M, Kaneda H, Nasu K, Matsuo H, Ehara M, Kinoshita Y, Kimura M, Tanaka N, Habara M, Katoh O, Suzuki T., Comparison of in vivo assessment of vulnerable plaque by 64-slice multislice computed tomography versus optical coherence tomography. Am J Cardiol 2011 107 1270 1277. doi: 10.1016/j.amjcard.2010.12.036.
61. Voros S, Rinehart S, Qian Z, Joshi P, Vazquez G, Fischer C, Belur P, Hulten E, Villines TC., Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis. JACC Cardiovasc Imaging 2011 4 537 548. doi: 10.1016/j.jcmg.2011.03.006.
62. Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, Naruse H, Ishii J, Hishida H, Wong ND, Virmani R, Kondo T, Ozaki Y, Narula J., Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009 54 49 57. doi: 10.1016/j.jacc.2009.02.068.
63. Suzuki S, Furui S, Kuwahara S, Kaminaga T, Yamauchi T, Konno K, Yokoyama N, Isshiki T., Accuracy of attenuation measurement of vascular wall in vitro on computed tomography angiography: Effect of wall thickness, density of contrast medium, and measurement point. Invest Radiol 2006 41 510 515. doi: 10.1097/01.rli.0000209662.24569.c7.
64. Achenbach S, Boehmer K, Pflederer T, Ropers D, Seltmann M, Lell M, Anders K, Kuettner A, Uder M, Daniel WG, Marwan M., Influence of slice thickness and reconstruction kernel on the computed tomographic attenuation of coronary atherosclerotic plaque. J Cardiovasc Comput Tomogr 2010 4 110 115. doi: 10.1016/j.jcct.2010.01.013.
65. Obaid DR, Calvert PA, Gopalan D, Parker RA, Hoole SP, West NE, Goddard M, Rudd JH, Bennett MR., Atherosclerotic plaque composition and classification identified by coronary computed tomography: assessment of computed tomography-generated plaque maps compared with virtual histology intravascular ultrasound and histology. Circ Cardiovasc Imaging 2013 6 655 664. doi: 10.1161/CIRCIMAGING.112.000250.
66. Hoffmann U, Moselewski F, Nieman K, Jang IK, Ferencik M, Rahman AM, Cury RC, Abbara S, Joneidi-Jafari H, Achenbach S, Brady TJ., Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. J Am Coll Cardiol 2006 47 1655 1662. doi: 10.1016/j.jacc.2006.01.041.
67. Varnava AM, Mills PG, Davies MJ., Relationship between coronary artery remodeling and plaque vulnerability. Circulation 2002 105 939 943
68. Hutcheson JD, Maldonado N, Aikawa E., Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability. Curr Opin Lipidol 2014 25 327 332. doi: 10.1097/MOL.0000000000000105.
69. Kataoka Y, Wolski K, Uno K, Puri R, Tuzcu EM, Nissen SE, Nicholls SJ., Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound. J Am Coll Cardiol 2012 59 1592 1597. doi: 10.1016/j.jacc.2012.03.012.
70. Maurovich-Horvat P, Hoffmann U, Vorpahl M, Nakano M, Virmani R, Alkadhi H., The napkin-ring sign: CT signature of high-risk coronary plaques? JACC Cardiovasc Imaging 2010 3 440 444. doi: 10.1016/j.jcmg.2010.02.003.
71. Otsuka K, Fukuda S, Tanaka A, Nakanishi K, Taguchi H, Yoshikawa J, Shimada K, Yoshiyama M., Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome. JACC Cardiovasc Imaging 2013 6 448 457. doi: 10.1016/j.jcmg.2012.09.016.
72. Puchner SB, Liu T, Mayrhofer T, Truong QA, Lee H, Fleg JL, Nagurney JT, Udelson JE, Hoffmann U, Ferencik M., High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial. J Am Coll Cardiol 2014 64 684 692. doi: 10.1016/j.jacc.2014.05.039.
73. Park HB, Heo R, ó Hartaigh B, Cho I, Gransar H, Nakazato R, Leipsic J, Mancini GB, Koo BK, Otake H, Budoff MJ, Berman DS, Erglis A, Chang HJ, Min JK., Atherosclerotic plaque characteristics by CT angiography identify coronary lesions that cause ischemia: a direct comparison to fractional flow reserve. JACC Cardiovasc Imaging 2015 8 1 10. doi: 10.1016/j.jcmg.2014.11.002.
74. Yuan C, Zhang SX, Polissar NL, Echelard D, Ortiz G, Davis JW, Ellington E, Ferguson MS, Hatsukami TS., Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation 2002 105 181 185
75. Gerretsen SC, Kooi ME, Kessels AG, Schalla S, Katoh M, van der Geest RJ, Manning WJ, Waltenberger J, van Engelshoven JM, Botnar RM, Leiner T., Visualization of coronary wall atherosclerosis in asymptomatic subjects and patients with coronary artery disease using magnetic resonance imaging. PLoS One 2010 5 e12998 e12999. doi: 10.1371/journal.pone.0012998.
76. Miao C, Chen S, Macedo R, Lai S, Liu K, Li D, Wasserman BA, Vogel-Claussen J, Vogel-Clausen J, Lima JA, Bluemke DA., Positive remodeling of the coronary arteries detected by magnetic resonance imaging in an asymptomatic population: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2009 53 1708 1715. doi: 10.1016/j.jacc.2008.12.063.
77. Kim WY, Christiansen EH, Thrysøe SA, Al-Mashhadi RH, Bøtker HE, Bøttcher M, Holm NR, Falk E., First in vivo demonstration of coronary edema in culprit lesion of patient with acute coronary syndrome by cardiovascular magnetic resonance. Circ Cardiovasc Imaging 2011 4 344 346. doi: 10.1161/CIRCIMAGING.110.963074.
78. Matsumoto K, Ehara S, Hasegawa T, Sakaguchi M, Otsuka K, Yoshikawa J, Shimada K., Localization of coronary high-intensity signals on T1-weighted MR imaging: relation to plaque morphology and clinical severity of angina pectoris. JACC Cardiovasc Imaging 2015 8 1143 1152. doi: 10.1016/j.jcmg.2015.06.013.
79. Noguchi T, Kawasaki T, Tanaka A, Yasuda S, Goto Y, Ishihara M, Nishimura K, Miyamoto Y, Node K, Koga N., High-intensity signals in coronary plaques on noncontrast T1-weighted magnetic resonance imaging as a novel determinant of coronary events. J Am Coll Cardiol 2014 63 989 999. doi: 10.1016/j.jacc.2013.11.034.
80. Yarnykh VL, Terashima M, Hayes CE, Shimakawa A, Takaya N, Nguyen PK, Brittain JH, McConnell MV, Yuan C., Multicontrast black-blood MRI of carotid arteries: comparison between 1.5 and 3 tesla magnetic field strengths. J Magn Reson Imaging 2006 23 691 698. doi: 10.1002/jmri.20562.
81. Bitar R, Moody AR, Leung G, Symons S, Crisp S, Butany J, Rowsell C, Kiss A, Nelson A, Maggisano R., In vivo 3D high-spatial-resolution MR imaging of intraplaque hemorrhage. Radiology 2008 249 259 267. doi: 10.1148/radiol.2491071517.
82. Albuquerque LC, Narvaes LB, Maciel AA, Staub H, Friedrich M, Filho JR, Marques MB, Rohde LE., Intraplaque hemorrhage assessed by high-resolution magnetic resonance imaging and C-reactive protein in carotid atherosclerosis. J Vasc Surg 2007 46 1130 1137. doi: 10.1016/j.jvs.2007.07.041.
83. van Dijk AC, Truijman MT, Hussain B, Zadi T, Saiedie G, de Rotte AA, Liem MI, van der Steen AF, Daemen MJ, Koudstaal PJ, Nederkoorn PJ, Hendrikse J, Kooi ME, van der Lugt A., Intraplaque hemorrhage and the plaque surface in carotid atherosclerosis: the plaque at risk study (PARISK). AJNR Am J Neuroradiol 2015 36 2127 2133. doi: 10.3174/ajnr.A4414.
84. Singh N, Moody AR, Gladstone DJ, Leung G, Ravikumar R, Zhan J, Maggisano R., Moderate carotid artery stenosis: MR imaging-depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men. Radiology 2009 252 502 508. doi: 10.1148/radiol.2522080792.
85. Cai J, Hatsukami TS, Ferguson MS, Kerwin WS, Saam T, Chu B, Takaya N, Polissar NL, Yuan C., In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005 112 3437 3444. doi: 10.1161/CIRCULATIONAHA.104.528174.
86. Takaya N, Yuan C, Chu B, Saam T, Underhill H, Cai J, Tran N, Polissar NL, Isaac C, Ferguson MS, Garden GA, Cramer SC, Maravilla KR, Hashimoto B, Hatsukami TS., Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI-initial results. Stroke 2006 37 818 823. doi: 10.1161/01.STR.0000204638.91099.91.
87. Chen H, Sun J, Kerwin WS, Balu N, Neradilek MB, Hippe DS, Isquith D, Xue Y, Yamada K, Peck S, Yuan C, O'Brien KD, Zhao XQ., Scan-rescan reproducibility of quantitative assessment of inflammatory carotid atherosclerotic plaque using dynamic contrast-enhanced 3T CMR in a multi-center study. J Cardiovasc Magn Reson 2014 16 51. doi: 10.1186/s12968-014-0051-7.
88. Bucerius J, Mani V, Moncrieff C, Machac J, Fuster V, Farkouh ME, Tawakol A, Rudd JH, Fayad ZA., Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels. Eur J Nucl Med Mol Imaging 2014 41 369 383. doi: 10.1007/s00259-013-2569-6.
89. Tarkin JM, Joshi FR, Rudd JH., PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol 2014 11 443 457. doi: 10.1038/nrcardio.2014.80.
90. Figueroa AL, Subramanian SS, Cury RC, Truong QA, Gardecki JA, Tearney GJ, Hoffmann U, Brady TJ, Tawakol A., Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology. Circ Cardiovasc Imaging 2012 5 69 77. doi: 10.1161/CIRCIMAGING.110.959478.
91. Marnane M, Merwick A, Sheehan OC, Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol 2012 71 709 718. doi: 10.1002/ana.23553.
92. Figueroa AL, Abdelbaky A, Truong QA, Corsini E, MacNabb MH, Lavender ZR, Lawler MA, Grinspoon SK, Brady TJ, Nasir K, Hoffmann U, Tawakol A., Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events. JACC Cardiovasc Imaging 2013 6 1250 1259. doi: 10.1016/j.jcmg.2013.08.006.
93. Moon SH, Cho YS, Noh TS, Choi JY, Kim BT, Lee KH., Carotid FDG Uptake Improves prediction of future cardiovascular events in asymptomatic individuals. JACC Cardiovasc Imaging 2015 8 949 956. doi: 10.1016/j.jcmg.2015.06.002.
94. Ogawa M, Nakamura S, Saito Y, Kosugi M, Magata Y., What can be seen by 18F-FDG PET in atherosclerosis imaging? The effect of foam cell formation on 18F-FDG uptake to macrophages in vitro. J Nucl Med 2012 53 55 58. doi: 10.2967/jnumed.111.092866.
95. Dunphy MP, Freiman A, Larson SM, Strauss HW., Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med 2005 46 1278 1284
96. Wenning C, Kloth C, Kuhlmann MT, Jacobs AH, Schober O, Hermann S, Schäfers MA., Serial F-18-FDG PET/CT distinguishes inflamed from stable plaque phenotypes in shear-stress induced murine atherosclerosis. Atherosclerosis 2014 234 276 282. doi: 10.1016/j.atherosclerosis.2014.03.008.
97. Satomi T, Ogawa M, Mori I, Ishino S, Kubo K, Magata Y, Nishimoto T., Comparison of contrast agents for atherosclerosis imaging using cultured macrophages: FDG versus ultrasmall superparamagnetic iron oxide. J Nucl Med 2013 54 999 1004. doi: 10.2967/jnumed.112.110551.
98. Gholami S, Salavati A, Houshmand S, Werner TJ, Alavi A., Assessment of atherosclerosis in large vessel walls: a comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification. J Nucl Cardiol 2015 22 468 479. doi: 10.1007/s12350-015-0069-8.
99. Folco EJ, Sheikine Y, Rocha VZ, Christen T, Shvartz E, Sukhova GK, Di Carli MF, Libby P., Hypoxia but not inflammation augments glucose uptake in human macrophages: implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-. d.-glucose positron emission tomography. J Am Coll Cardiol 2011 58 603 614. doi: 10.1016/j.jacc.2011.03.044.
100. Taqueti VR, Di Carli MF, Jerosch-Herold M, Sukhova GK, Murthy VL, Folco EJ, Kwong RY, Ozaki CK, Belkin M, Nahrendorf M, Weissleder R, Libby P., Increased microvascularization and vessel permeability associate with active inflammation in human atheromata. Circ Cardiovasc Imaging 2014 7 920 929. doi: 10.1161/CIRCIMAGING.114.002113.
101. Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, Kolodny G, Laham R., Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 2009 50 563 568. doi: 10.2967/jnumed.108.055616.
102. Ye YX, Calcagno C, Binderup T, Imaging macrophage and hematopoietic progenitor proliferation in atherosclerosis. Circ Res 2015 117 835 845. doi: 10.1161/CIRCRESAHA.115.307024.
103. Caobelli F, Bengel FM., In vivo evaluation of atherosclerotic plaques and culprit lesions using noninvasive techniques. Nat Rev Cardiol 2015 12 79. doi: 10.1038/nrcardio.2014.80-c1.
104. 99mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery. Eur J Nucl Med Mol Imaging 2014 41 1710 1719. doi: 10.1007/s00259-014-2764-0.
105. Jager NA, Westra J, Golestani R, van Dam GM, Low PS, Tio RA, Slart RH, Boersma HH, Bijl M, Zeebregts CJ., Folate receptor-β imaging using 99mTc-folate to explore distribution of polarized macrophage populations in human atherosclerotic plaque. J Nucl Med 2014 55 1945 1951. doi: 10.2967/jnumed.114.143180.
106. Broisat A, Toczek J, Dumas LS, Ahmadi M, Bacot S, Perret P, Slimani L, Barone-Rochette G, Soubies A, Devoogdt N, Lahoutte T, Fagret D, Riou LM, Ghezzi C., 99mTc-cAbVCAM1-5 imaging is a sensitive and reproducible tool for the detection of inflamed atherosclerotic lesions in mice. J Nucl Med 2014 55 1678 1684. doi: 10.2967/jnumed.114.143792.
107. Kolodgie FD, Petrov A, Virmani R, Narula N, Verjans JW, Weber DK, Hartung D, Steinmetz N, Vanderheyden JL, Vannan MA, Gold HK, Reutelingsperger CP, Hofstra L, Narula J., Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 2003 108 3134 3139. doi: 10.1161/01.CIR.0000105761.00573.50.
108. Morishige K, Kacher DF, Libby P, Josephson L, Ganz P, Weissleder R, Aikawa M., High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis. Circulation 2010 122 1707 1715. doi: 10.1161/CIRCULATIONAHA.109.891804.
109. Howarth SP, Tang TY, Trivedi R, Weerakkody R, U-King-Im J, Gaunt ME, Boyle JR, Li ZY, Miller SR, Graves MJ, Gillard JH., Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals. Eur J Radiol 2009 70 555 560. doi: 10.1016/j.ejrad.2008.01.047.
110. Trivedi RA, Mallawarachi C, U-King-Im JM, Graves MJ, Horsley J, Goddard MJ, Brown A, Wang L, Kirkpatrick PJ, Brown J, Gillard JH., Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 2006 26 1601 1606. doi: 10.1161/01.ATV.0000222920.59760.df.
111. McAteer MA, Schneider JE, Ali ZA, Warrick N, Bursill CA, von zur Muhlen C, Greaves DR, Neubauer S, Channon KM, Choudhury RP., Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler Thromb Vasc Biol 2008 28 77 83. doi: 10.1161/ATVBAHA.107.145466.
112. Segers FM, den Adel B, Bot I, van der Graaf LM, van der Veer EP, Gonzalez W, Raynal I, de Winther M, Wodzig WK, Poelmann RE, van Berkel TJ, van der Weerd L, Biessen EA., Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2013 33 1812 1819. doi: 10.1161/ATVBAHA.112.300707.
113. Makowski MR, Wiethoff AJ, Blume U, Cuello F, Warley A, Jansen CH, Nagel E, Razavi R, Onthank DC, Cesati RR, Marber MS, Schaeffter T, Smith A, Robinson SP, Botnar RM., Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nat Med 2011 17 383 388. doi: 10.1038/nm.2310.
114. Hyafil F, Cornily JC, Feig JE, Gordon R, Vucic E, Amirbekian V, Fisher EA, Fuster V, Feldman LJ, Fayad ZA., Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 2007 13 636 641. doi: 10.1038/nm1571.
115. Danad I, Fayad ZA, Willemink MJ, Min JK., New applications of cardiac computed tomography: dual-energy, spectral, and molecular CT imaging. JACC Cardiovasc Imaging 2015 8 710 723. doi: 10.1016/j.jcmg.2015.03.005.
116. Lindner JR., Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nat Rev Cardiol 2009 6 475 481. doi: 10.1038/nrcardio.2009.77.
117. Behm CZ, Kaufmann BA, Carr C, Lankford M, Sanders JM, Rose CE, Kaul S, Lindner JR., Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis. Circulation 2008 117 2902 2911. doi: 10.1161/CIRCULATIONAHA.107.744037.
118. Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K., Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 2001 104 2107 2112
119. Jaffer FA, Calfon MA, Rosenthal A, Mallas G, Razansky RN, Mauskapf A, Weissleder R, Libby P, Ntziachristos V., Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J Am Coll Cardiol 2011 57 2516 2526. doi: 10.1016/j.jacc.2011.02.036.
120. Lee S, Lee MW, Cho HS, Song JW, Nam HS, Oh DJ, Park K, Oh WY, Yoo H, Kim JW., Fully integrated high-speed intravascular optical coherence tomography/near-infrared fluorescence structural/molecular imaging in vivo using a clinically available near-infrared fluorescence-emitting indocyanine green to detect inflamed lipid-rich atheromata in coronary-sized vessels. Circ Cardiovasc Interv 2014 7 560 569. doi: 10.1161/CIRCINTERVENTIONS.114.001498.
121. Press MC, Jaffer FA., Molecular intravascular imaging approaches for atherosclerosis. Curr Cardiovasc Imaging Rep 2014 7 9293. doi: 10.1007/s12410-014-9293-x.
122. McKenney-Drake ML, Territo PR, Salavati A, Houshmand S, Persohn S, Liang Y, Alloosh M, Moe SM, Weaver CM, Alavi A, Sturek M., (18)F-NaF PET imaging of early coronary artery calcification [published online ahead of print July 8, 2015]. JACC Cardiovasc Imaging. doi: 10.1016/j.jcmg.2015.02.026.
123. Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, Joshi FR, Gallagher FA, Warburton EA, Bennett MR, Brindle KM, Newby DE, Rudd JH, Davenport AP., Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun 2015 6 7495. doi: 10.1038/ncomms8495.
124. Marsch E, Sluimer JC, Daemen MJ., Hypoxia in atherosclerosis and inflammation. Curr Opin Lipidol 2013 24 393 400. doi: 10.1097/MOL.0b013e32836484a4.
125. van der Valk FM, Kroon J, Potters WV, Thurlings RM, Bennink RJ, Verberne HJ, Nederveen AJ, Nieuwdorp M, Mulder WJ, Fayad ZA, van Buul JD, Stroes ES., In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humans. J Am Coll Cardiol 2014 64 1019 1029. doi: 10.1016/j.jacc.2014.06.1171.
126. 18F-fluoromisonidazole positron emission tomographic imaging. Circ Cardiovasc Imaging 2014 7 312 320. doi: 10.1161/CIRCIMAGING.113.001084.
127. Joshi FR, Manavak R, Fryer TD, Buscombe JR, Smith R, Figg N, Gillard JH, Young V, Aigbirhio FI, Davenport A, Kirkpatrick PJ, Warburton EA, Rudd JHF., Abstract 14673: imaging of hypoxia and inflammation in carotid atherosclerosis with 18F-fluoromisonidazole and 18F-fluorodeoxyglucose positron emission tomography. Circulation 2013. [Abstract]
128. Beer AJ, Pelisek J, Heider P, Saraste A, Reeps C, Metz S, Seidl S, Kessler H, Wester HJ, Eckstein HH, Schwaiger M., PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis. JACC Cardiovasc Imaging 2014 7 178 187. doi: 10.1016/j.jcmg.2013.12.003.
129. Yoo JS, Lee J, Jung JH, Moon BS, Kim S, Lee BC, Kim SE., SPECT/CT Imaging of High-Risk Atherosclerotic Plaques using Integrin-Binding RGD Dimer Peptides. Sci Rep 2015 1 11
130. Pedrigi RM, de Silva R, Bovens SM, Mehta VV, Petretto E, Krams R., Thin-cap fibroatheroma rupture is associated with a fine interplay of shear and wall stress. Arterioscler Thromb Vasc Biol 2014 34 2224 2231. doi: 10.1161/ATVBAHA.114.303426.
131. Pedrigi RM, Poulsen CB, Mehta VV, Inducing persistent flow disturbances accelerates atherogenesis and promotes thin cap fibroatheroma development in D374Y-PCSK9 hypercholesterolemic minipigs. Circulation 2015 132 1003 1012. doi: 10.1161/CIRCULATIONAHA.115.016270.
132. Kwak BR, Bäck M, Bochaton-Piallat ML, Biomechanical factors in atherosclerosis: mechanisms and clinical implications. Eur Heart J 2014 35 3013 20, 3020a. doi: 10.1093/eurheartj/ehu353.
133. Samady H, Eshtehardi P, McDaniel MC, Suo J, Dhawan SS, Maynard C, Timmins LH, Quyyumi AA, Giddens DP., Coronary artery wall shear stress is associated with progression and transformation of atherosclerotic plaque and arterial remodeling in patients with coronary artery disease. Circulation 2011 124 779 788. doi: 10.1161/CIRCULATIONAHA.111.021824.
134. Teng Z, Brown AJ, Calvert PA, Parker RA, Obaid DR, Huang Y, Hoole SP, West NE, Gillard JH, Bennett MR., Coronary plaque structural stress is associated with plaque composition and subtype and higher in acute coronary syndrome: the BEACON I (Biomechanical Evaluation of Atheromatous Coronary Arteries) study. Circ Cardiovasc Imaging 2014 7 461 470. doi: 10.1161/CIRCIMAGING.113.001526.
135. Koo BK, Erglis A, Doh JH, Daniels DV, Jegere S, Kim HS, Dunning A, DeFrance T, Lansky A, Leipsic J, Min JK., Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J Am Coll Cardiol 2011 58 1989 1997. doi: 10.1016/j.jacc.2011.06.066.
136. Nørgaard BL, Leipsic J, Gaur S, NXT Trial Study Group Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). J Am Coll Cardiol 2014 63 1145 1155. doi: 10.1016/j.jacc.2013.11.043.
137. Kim KH, Doh JH, Koo BK, Min JK, Erglis A, Yang HM, Park KW, Lee HY, Kang HJ, Kim YJ, Lee SY, Kim HS., A novel noninvasive technology for treatment planning using virtual coronary stenting and computed tomography-derived computed fractional flow reserve. JACC Cardiovasc Interv 2014 7 72 78. doi: 10.1016/j.jcin.2013.05.024.
138. Douglas PS, Pontone G, Hlatky MA, PLATFORM Investigators Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFRCT: outcome and resource impacts study. Eur Heart J 2015 36 3359 3367. doi: 10.1093/eurheartj/ehv444.
139. Arbab-Zadeh A, Fuster V., The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol 2015 65 846 855. doi: 10.1016/j.jacc.2014.11.041.
140. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA., Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008 358 1336 1345. doi: 10.1056/NEJMoa072100.
141. Criqui MH, Denenberg JO, Ix JH, McClelland RL, Wassel CL, Rifkin DE, Carr JJ, Budoff MJ, Allison MA., Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 2014 311 271 278. doi: 10.1001/jama.2013.282535.
142. Erbel R, Lehmann N, Churzidse S, Heinz Nixdorf Recall Study Investigators Progression of coronary artery calcification seems to be inevitable, but predictable-results of the Heinz Nixdorf Recall (HNR) study. Eur Heart J 2014 35 2960 2971. doi: 10.1093/eurheartj/ehu288.
143. Puri R, Nicholls SJ, Shao M, Kataoka Y, Uno K, Kapadia SR, Tuzcu EM, Nissen SE., Impact of statins on serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol 2015 65 1273 1282. doi: 10.1016/j.jacc.2015.01.036.
144. Valenti V, Ó Hartaigh B, Heo R, A 15-Year Warranty Period for Asymptomatic Individuals Without Coronary Artery Calcium: A Prospective Follow-Up of 9,715 Individuals. JACC Cardiovasc Imaging 2015 8 900 909. doi: 10.1016/j.jcmg.2015.01.025.
145. Nasir K, Bittencourt MS, Blaha MJ, Blankstein R, Agatson AS, Rivera JJ, Miemdema MD, Sibley CT, Shaw LJ, Blumenthal RS, Budoff MJ, Krumholz HM., Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2015 66 1657 1668. doi: 10.1016/j.jacc.2015.07.066.
146. Baber U, Mehran R, Sartori S, Schoos MM, Sillesen H, Muntendam P, Garcia MJ, Gregson J, Pocock S, Falk E, Fuster V., Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J Am Coll Cardiol 2015 65 1065 1074. doi: 10.1016/j.jacc.2015.01.017.
147. Arbab-Zadeh A, Nakano M, Virmani R, Fuster V., Acute coronary events. Circulation 2012 125 1147 1156. doi: 10.1161/CIRCULATIONAHA.111.047431.
148. Marzilli M, Merz CN, Boden WE, Bonow RO, Capozza PG, Chilian WM, DeMaria AN, Guarini G, Huqi A, Morrone D, Patel MR, Weintraub WS., Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J Am Coll Cardiol 2012 60 951 956. doi: 10.1016/j.jacc.2012.02.082.
149. Zimmermann FM, Ferrara A, Johnson NP, van Nunen LX, Escaned J, Albertsson P, Erbel R, Legrand V, Gwon HC, Remkes WS, Stella PR, van Schaardenburgh P, Bech GJ, De Bruyne B, Pijls NH., Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J 2015 36 3182 3188. doi: 10.1093/eurheartj/ehv452.
150. Boden WE, O'Rourke RA, Teo KK, COURAGE Trial Research Group Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007 356 1503 1516. doi: 10.1056/NEJMoa070829.
151. Frye RL, August P, Brooks MM, BARI 2D Study Group A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009 360 2503 2515
152. Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D, Rocha AS, Hueb AC, Ramires JA., Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2010 122 949 957. doi: 10.1161/CIRCULATIONAHA.109.911669.
153. Dangas GD, Farkouh ME, Sleeper LA, Yang M, Schoos MM, Macaya C, Abizaid A, Buller CE, Devlin G, Rodriguez AE, Lansky AJ, Siami FS, Domanski M, Fuster V, FREEDOM Investigators Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. J Am Coll Cardiol 2014 64 1189 1197. doi: 10.1016/j.jacc.2014.06.1182.
154. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR Jr, Morel MA, Van Dyck N, Houle VM, Dawkins KD, Serruys PW., Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013 381 629 638. doi: 10.1016/S0140-6736(13)60141-5.
155. Puri R, Nicholls SJ, Ellis SG, Tuzcu EM, Kapadia SR., High-risk coronary atheroma: the interplay between ischemia, plaque burden, and disease progression. J Am Coll Cardiol 2014 63 1134 1140. doi: 10.1016/j.jacc.2013.05.088.
156. Johnson NP, Tóth GG, Lai D, Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol 2014 64 1641 1654. doi: 10.1016/j.jacc.2014.07.973.
157. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW, PROSPECT Investigators A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011 364 226 235. doi: 10.1056/NEJMoa1002358.
158. Calvert PA, Obaid DR, O'Sullivan M, Shapiro LM, McNab D, Densem CG, Schofield PM, Braganza D, Clarke SC, Ray KK, West NE, Bennett MR., Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study. JACC Cardiovasc Imaging 2011 4 894 901. doi: 10.1016/j.jcmg.2011.05.005.
159. Cheng JM, Garcia-Garcia HM, de Boer SP, Kardys I, Heo JH, Akkerhuis KM, Oemrawsingh RM, van Domburg RT, Ligthart J, Witberg KT, Regar E, Serruys PW, van Geuns RJ, Boersma E., In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Eur Heart J 2014 35 639 647. doi: 10.1093/eurheartj/eht484.
160. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ., Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation 2004 110 928 933. doi: 10.1161/01.CIR.0000139858.69915.2E.
161. Kubo T, Maehara A, Mintz GS, The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol 2010 55 1590 1597. doi: 10.1016/j.jacc.2009.07.078.
162. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, Virmani R., Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001 103 934 940
163. Ahmadi A, Leipsic J, Blankstein R, Taylor C, Hecht H, Stone GW, Narula J., Do plaques rapidly progress prior to myocardial infarction? The interplay between plaque vulnerability and progression. Circ Res 2015 117 99 104. doi: 10.1161/CIRCRESAHA.117.305637.
164. Tian J, Ren X, Vergallo R, Xing L, Yu H, Jia H, Soeda T, McNulty I, Hu S, Lee H, Yu B, Jang IK., Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study. J Am Coll Cardiol 2014 63 2209 2216. doi: 10.1016/j.jacc.2014.01.061.
165. Vergallo R, Ren X, Yonetsu T, Pancoronary plaque vulnerability in patients with acute coronary syndrome and ruptured culprit plaque: a 3-vessel optical coherence tomography study. Am Heart J 2014 167 59 67. doi: 10.1016/j.ahj.2013.10.011.
166. Stone PH, Saito S, Takahashi S, PREDICTION Investigators Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION study. Circulation 2012 126 172 181. doi: 10.1161/CIRCULATIONAHA.112.096438.
167. Motoyama S, Ito H, Sarai M, Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up. J Am Coll Cardiol 2015 66 337 346. doi: 10.1016/j.jacc.2015.05.069.
168. Douglas PS, Hoffmann U, Patel MR, PROMISE Investigators Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 2015 372 1291 1300. doi: 10.1056/NEJMoa1415516.
169. Sandfort V, Lima JA, Bluemke DA., noninvasive imaging of atherosclerotic plaque progression: status of coronary computed tomography angiography. Circ Cardiovasc Imaging 2015 8 e003316. doi: 10.1161/CIRCIMAGING.115.003316.
170. Mushtaq S, De Araujo Gonçalves P, Garcia-Garcia HM, Pontone G, Bartorelli AL, Bertella E, Campos CM, Pepi M, Serruys PW, Andreini D., Long-term prognostic effect of coronary atherosclerotic burden: validation of the computed tomography-Leaman score. Circ Cardiovasc Imaging 2015 8 e002332. doi: 10.1161/CIRCIMAGING.114.002332.
171. Joshi NV, Toor I, Shah AS, Systemic atherosclerotic inflammation following acute myocardial infarction: myocardial infarction begets myocardial infarction. J Am Heart Assoc 2015 4 e001956. doi: 10.1161/JAHA.115.001956.
172. Emami H, Singh P, MacNabb M, Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans. JACC Cardiovasc Imaging 2015 8 121 130. doi: 10.1016/j.jcmg.2014.10.009.
173. Bos D, Shahzad R, van Walsum T, van Vliet LJ, Franco OH, Hofman A, Niessen WJ, Vernooij MW, van der Lugt A., Epicardial fat volume is related to atherosclerotic calcification in multiple vessel beds. Eur Heart J Cardiovasc Imaging 2015 16 1264 1269. doi: 10.1093/ehjci/jev086.
174. Bucerius J, Mani V, Wong S, Moncrieff C, Izquierdo-Garcia D, Machac J, Fuster V, Farkouh ME, Rudd JH, Fayad ZA., Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study. Eur J Nucl Med Mol Imaging 2014 41 934 945. doi: 10.1007/s00259-013-2653-y.
175. Fryburg DA, Vassileva MT., Atherosclerosis drug development in jeopardy: the need for predictive biomarkers of treatment response. Sci Transl Med 2011 3 72cm6. doi: 10.1126/scitranslmed.3002029.
176. Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, Raichlen JS, Uno K, Borgman M, Wolski K, Nissen SE., Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med 2011 365 2078 2087. doi: 10.1056/NEJMoa1110874.
177. Crea F, Niccoli G., Ezetimibe and plaque regression: cholesterol lowering or pleiotropic effects? J Am Coll Cardiol 2015 66 508 510. doi: 10.1016/j.jacc.2015.05.064.
178. Nissen SE, Nicholls SJ, Sipahi I, ASTEROID Investigators Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006 295 1556 1565. doi: 10.1001/jama.295.13.jpc60002.
179. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN, REVERSAL Investigators Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004 291 1071 1080. doi: 10.1001/jama.291.9.1071.
180. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, Daida H., Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation 2004 110 1061 1068. doi: 10.1161/01.CIR.0000140261.58966.A4.
181. Räber L, Taniwaki M, Zaugg S, Kelbæk H, Roffi M, Holmvang L, Noble S, Pedrazzini G, Moschovitis A, Lüscher TF, Matter CM, Serruys PW, Jüni P, Garcia-Garcia HM, Windecker S, IBIS 4 (Integrated Biomarkers and Imaging Study-4) Trial Investigators (NCT00962416) Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study. Eur Heart J 2015 36 490 500. doi: 10.1093/eurheartj/ehu373.
182. Tsujita K, Sugiyama S, Sumida H, PRECISE-IVUS Investigators Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: the multicenter randomized controlled PRECISE-IVUS trial. J Am Coll Cardiol 2015 66 495 507. doi: 10.1016/j.jacc.2015.05.065.
183. Hirohata A, Yamamoto K, Miyoshi T, Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial. J Am Coll Cardiol 2010 55 976 982. doi: 10.1016/j.jacc.2009.09.062.
184. Hattori K, Ozaki Y, Ismail TF, Okumura M, Naruse H, Kan S, Ishikawa M, Kawai T, Ohta M, Kawai H, Hashimoto T, Takagi Y, Ishii J, Serruys PW, Narula J., Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging 2012 5 169 177. doi: 10.1016/j.jcmg.2011.11.012.
185. Libby P., How does lipid lowering prevent coronary events? New insights from human imaging trials. Eur Heart J 2015 36 472 474. doi: 10.1093/eurheartj/ehu510.
186. Fleg JL, Mete M, Howard BV, Umans JG, Roman MJ, Ratner RE, Silverman A, Galloway JM, Henderson JA, Weir MR, Wilson C, Stylianou M, Howard WJ., Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial. J Am Coll Cardiol 2008 52 2198 2205. doi: 10.1016/j.jacc.2008.10.031.
187. Crouse JR III, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML, METEOR Study Group Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007 297 1344 1353. doi: 10.1001/jama.297.12.1344.
188. Underhill HR, Yuan C, Zhao XQ, Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am Heart J 2008 155 584.e1 584.e8. doi: 10.1016/j.ahj.2007.11.018.
189. Zhao XQ, Dong L, Hatsukami T, Phan BA, Chu B, Moore A, Lane T, Neradilek MB, Polissar N, Monick D, Lee C, Underhill H, Yuan C., MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course. JACC Cardiovasc Imaging 2011 4 977 986. doi: 10.1016/j.jcmg.2011.06.013.
190. Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardif JC, Rudd JH, Farkouh ME, Tawakol A, dal-PLAQUE Investigators Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet 2011 378 1547 1559. doi: 10.1016/S0140-6736(11)61383-4.
191. Schwartz GG, Olsson AG, Abt M, dal-OUTCOMES Investigators Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012 367 2089 2099. doi: 10.1056/NEJMoa1206797.
192. Sibley CT, Vavere AL, Gottlieb I, Cox C, Matheson M, Spooner A, Godoy G, Fernandes V, Wasserman BA, Bluemke DA, Lima JA., MRI-measured regression of carotid atherosclerosis induced by statins with and without niacin in a randomised controlled trial: the NIA plaque study. Heart 2013 99 1675 1680. doi: 10.1136/heartjnl-2013-303926.
193. Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W, AIM-HIGH Investigators Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011 365 2255 2267
194. Tang TY, Howarth SP, Miller SR, The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol 2009 53 2039 2050. doi: 10.1016/j.jacc.2009.03.018.
195. Lo J, Lu MT, Ihenachor EJ, Wei J, Looby SE, Fitch KV, Oh J, Zimmerman CO, Hwang J, Abbara S, Plutzky J, Robbins G, Tawakol A, Hoffmann U, Grinspoon SK., Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. Lancet HIV 2015 2 e52 e63. doi: 10.1016/S2352-3018(14)00032-0.
196. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, Hayabuchi N, Imaizumi T., Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006 48 1825 1831. doi: 10.1016/j.jacc.2006.03.069.
197. Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, Subramanian SS, Abdelbaky A, Rudd JH, Farkouh ME, Nunes IO, Beals CR, Shankar SS., Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. J Am Coll Cardiol 2013 62 909 917. doi: 10.1016/j.jacc.2013.04.066.
198. Mizoguchi M, Tahara N, Tahara A, Nitta Y, Kodama N, Oba T, Mawatari K, Yasukawa H, Kaida H, Ishibashi M, Hayabuchi N, Harada H, Ikeda H, Yamagishi S, Imaizumi T., Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta. JACC Cardiovasc Imaging 2011 4 1110 1118. doi: 10.1016/j.jcmg.2011.08.007.
199. Tawakol A, Singh P, Rudd JH, Soffer J, Cai G, Vucic E, Brannan SP, Tarka EA, Shaddinger BC, Sarov-Blat L, Matthews P, Subramanian S, Farkouh M, Fayad ZA., Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging. J Am Coll Cardiol 2014 63 86 88. doi: 10.1016/j.jacc.2013.07.050.
200. White HD, Held C, Stewart R, STABILITY Investigators Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med 2014 370 1702 1711
201. O'Donoghue ML, Braunwald E, White HD, SOLID-TIMI 52 Investigators Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA 2014 312 1006 1015. doi: 10.1001/jama.2014.11061.
202. Deseive S, Chen MY, Korosoglou G, Leipsic J, Martuscelli E, Carrascosa P, Mirsadraee S, White C, Hadamitzky M, Martinoff S, Menges A-L, Bischoff B, Massberg S, Hausleiter J., Prospective randomized trial on radiation dose estimates of CT angiography applying iterative image reconstruction: the PROTECTION V study. JACC Cardiovasc Imaging 2015 8 888 896. doi: 10.1016/j.jcmg.2015.02.024.
203. Obaid DR, Calvert PA, Gopalan D, Parker RA, West NE, Goddard M, Rudd JH, Bennett MR., Dual-energy computed tomography imaging to determine atherosclerotic plaque composition: a prospective study with tissue validation. J Cardiovasc Comput Tomogr 2014 8 230 237. doi: 10.1016/j.jcct.2014.04.007.
204. 18F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA study. J Nucl Cardiol 2014 21 588 597. doi: 10.1007/s12350-014-9884-6.
205. Bettinardi V, Castiglioni I, De Bernardi E, Gilardi MC., PET quantification: strategies for partial volume correction. Clin Transl Imaging 2014 2 199 218
206. Coppo S, Piccini D, Bonanno G, Chaptinel J, Vincenti G, Feliciano H, van Heeswijk RB, Schwitter J, Stuber M., Free-running 4D whole-heart self-navigated golden angle MRI: initial results. Magn Reson Med 2015 74 1306 1316. doi: 10.1002/mrm.25523.
207. Fayad HJ, Lamare F, Le Rest CC, Bettinardi V, Visvikis D., Generation of 4-dimensional CT images based on 4-dimensional PET-derived motion fields. J Nucl Med 2013 54 631 638. doi: 10.2967/jnumed.112.110809.
208. Rubeaux M, Joshi NV, Dweck MR, Fletcher A, Motwani M, Thomson LE, Germano G, Dey D, Li D, Berman DS, Newby DE, Slomka PJ., Motion Correction of 18F-NaF PET for Imaging Coronary Atherosclerotic Plaques. J Nucl Med 2016 57 54 59. doi: 10.2967/jnumed.115.162990.